Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.4M
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
28.3M
-
Shares change
-
+89.2K
-
Total reported value, excl. options
-
$2.64B
-
Value change
-
+$18.3M
-
Put/Call ratio
-
0.98
-
Number of buys
-
120
-
Number of sells
-
-137
-
Price
-
$93.02
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q2 2020
306 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q2 2020.
Medpace Holdings, Inc. - Common Stock (MEDP) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.3M shares
of 28.4M outstanding shares and own 99.75% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.59M shares), VANGUARD GROUP INC (3.63M shares), WASATCH ADVISORS INC (2.56M shares), Pendal Group Ltd (1.08M shares), RENAISSANCE TECHNOLOGIES LLC (873K shares), FULLER & THALER ASSET MANAGEMENT, INC. (863K shares), STATE STREET CORP (862K shares), PRICE T ROWE ASSOCIATES INC /MD/ (784K shares), Invesco Ltd. (748K shares), and DIMENSIONAL FUND ADVISORS LP (668K shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.